Showing 1 - 9 results of 9 for search 'Jutamaad Satayavivad', query time: 0.14s
Refine Results
-
1
A comprehensive review on disposition kinetics and dosage of oral administration of Andrographis paniculata, an alternative herbal medicine, in co-treatment of coronavirus disease by Phanit Songvut, Tawit Suriyo, Tawit Suriyo, Duangchit Panomvana, Nuchanart Rangkadilok, Nuchanart Rangkadilok, Jutamaad Satayavivad, Jutamaad Satayavivad
Published 2022-08-01
Article -
2
-
3
Comparative pharmacokinetics and safety evaluation of high dosage regimens of Andrographis paniculata aqueous extract after single and multiple oral administration in healthy parti... by Phanit Songvut, Nuchanart Rangkadilok, Nuchanart Rangkadilok, Nanthanit Pholphana, Tawit Suriyo, Tawit Suriyo, Duangchit Panomvana, Porranee Puranajoti, Jaratluck Akanimanee, Jutamaad Satayavivad, Jutamaad Satayavivad
Published 2023-08-01
Article -
4
Generation of bispecific antibodies by structure-guided redesign of IgG constant regions by Yordkhwan W. Iwasaki, Kannan Tharakaraman, Vidya Subramanian, Amnart Khongmanee, Andrew Hatas, Eduardo Fleischer, Troy T. Rurak, Patchara Ngok-ngam, Phanthakarn Tit-oon, Mathuros Ruchirawat, Mathuros Ruchirawat, Jutamaad Satayavivad, Jutamaad Satayavivad, Jutamaad Satayavivad, Mayuree Fuangthong, Mayuree Fuangthong, Mayuree Fuangthong, Ram Sasisekharan, Ram Sasisekharan
Published 2023-01-01
Article -
5
Method Validation for Quantification of PFOS and PFOA in Human Plasma and a Pilot Study in Blood Donors from Thai Red Cross Society by Teerapong Lertassavakorn, Nanthanit Pholphana, Nuchanart Rangkadilok, Tawit Suriyo, Punthip Teeyapant, Jutamaad Satayavivad
Published 2023-12-01
Article -
6
A validated LC–MS/MS method for clinical pharmacokinetics and presumptive phase II metabolic pathways following oral administration of Andrographis paniculata extract by Phanit Songvut, Nanthanit Pholphana, Tawit Suriyo, Nuchanart Rangkadilok, Duangchit Panomvana, Porranee Puranajoti, Jutamaad Satayavivad
Published 2023-02-01
Article -
7
Arsenic induces the global hypophosphorylation of insulin receptor substrate proteins in differentiated human neuroblastoma SH-SY5Y cells by Churaibhon Wisessaowapak, Churat Weeraphan, Daranee Visitnonthachai, Daranee Chokchaichamnankit, Chantragan Srisomsap, Piyajit Watcharasit, Jisnuson Svasti, Jutamaad Satayavivad
Published 2023-03-01
Article -
8
Correction: Lertsuwan et al. CX-4945 Induces Methuosis in Cholangiocarcinoma Cell Lines by a CK2-Independent Mechanism. <i>Cancers</i> 2018, <i>10</i>, 283 by Jomnarong Lertsuwan, Kornkamon Lertsuwan, Anyaporn Sawasdichai, Nathapol Tasnawijitwong, Ka Ying Lee, Philip Kitchen, Simon Afford, Kevin Gaston, Padma-Sheela Jayaraman, Jutamaad Satayavivad
Published 2022-12-01
Article -
9
CX-4945 Induces Methuosis in Cholangiocarcinoma Cell Lines by a CK2-Independent Mechanism by Jomnarong Lertsuwan, Kornkamon Lertsuwan, Anyaporn Sawasdichai, Nathapol Tasnawijitwong, Ka Ying Lee, Philip Kitchen, Simon Afford, Kevin Gaston, Padma-Sheela Jayaraman, Jutamaad Satayavivad
Published 2018-08-01
Article